Viewing Study NCT00526292

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 3:44 PM
Ignite Modification Date: 2026-03-01 @ 9:58 AM
Study NCT ID: NCT00526292
Status: COMPLETED
Last Update Posted: 2016-02-12
First Post: 2007-09-05
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Chemotherapy and a Donor Natural Killer Cell Infusion in Treating Patients With Relapsed or Persistent Leukemia or Myelodysplastic Syndrome After a Donor Stem Cell Transplant
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Leukemia View
None Myelodysplastic Syndromes View
Keywords:

Keywords

Keyword Brief Keyword Text View
None recurrent adult acute lymphoblastic leukemia View
None recurrent adult acute myeloid leukemia View
None blastic phase chronic myelogenous leukemia View
None previously treated myelodysplastic syndromes View
None childhood myelodysplastic syndromes View
None recurrent childhood acute lymphoblastic leukemia View
None recurrent childhood acute myeloid leukemia View
None childhood chronic myelogenous leukemia View
None relapsing chronic myelogenous leukemia View
None adult acute myeloid leukemia with 11q23 (MLL) abnormalities View
None adult acute myeloid leukemia with inv(16)(p13;q22) View
None adult acute myeloid leukemia with t(15;17)(q22;q12) View
None adult acute myeloid leukemia with t(16;16)(p13;q22) View
None adult acute myeloid leukemia with t(8;21)(q22;q22) View